Characterization of fibrinogen glycosylation and its importance for serum/plasma N-glycome analysis

Journal of Proteome Research

Volumn 12, Issue 1, 2013, Pages 444-454

  Adamczyk, Barbara ^a   Struwe, Weston B ^a   Ercan, Altan ^b   Nigrovic, Peter A ^b,c   Rudd, Pauline M ^a  

^a NATIONAL INSTITUTE FOR BIOPROCESSING RESEARCH AND TRAINING   (Ireland)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Fibrinogen; Glycan analysis; HILIC HPLC; Plasma; Serum

Indexed keywords

BIOLOGICAL MARKER; FIBRINOGEN; GLYCAN; OLIGOSACCHARIDE;

ARTICLE; GLYCOSYLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROPHILIC INTERACTION CHROMATOGRAPHY; PLASMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN STRUCTURE; SERUM;

BLOOD PROTEINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FIBRINOGEN; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; OLIGOSACCHARIDES; POLYSACCHARIDES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84874034422     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr300813h     Document Type: Article

References (42)

1. Mrozinski, P.; Zolotarjova, N.; Chen, H. Human Serum and Plasma Protein Depletion-Novel High-Capacity Affinity Column for the Removal of the Top 14 Abundant Proteins. Poster presentation, 2008.
2. Chromy, B. A.; Gonzales, A. D.; Perkins, J.; Choi, M. W.; Corzett, M. H.; Chang, B. C.; Corzett, C. H.; McCutchen-Maloney, S. L. Proteomic Analysis of Human Serum by Two-Dimensional Differential Gel Electrophoresis after Depletion of High-Abundant Proteins. J. Proteome Res. 2004, 3 (6), 1120-1127.
3. Nicol, G.; Martosella, J.; Yang, L. S.; Szafranski, C.; Bailey, J.; Boyesm B. Agilent multiple affinity removal system for the depletion of high-abundant proteins from human serum-a new technology from Agilent. Poster presentation, 2003
4. Anderson, N. L.; Anderson, N. G. The Human Plasma Proteome. Mol. Cell. Proteomics 2002, 1 (11), 845-867.
5. Omenn, G. S.; States, D. J.; Adamski, M.; Blackwell, T. W.; Menon, R.; Hermjakob, H.; Apweiler, R.; Haab, B. B.; Simpson, R. J.; Eddes, J. S.; Kapp, E. A.; Moritz, R. L.; Chan, D. W.; Rai, A. J.; Admon, A.; Aebersold, R.; Eng, J.; Hancock, W. S.; Hefta, S. A.; Meyer, H.; Paik, Y.-K.; Yoo, J.-S.; Ping, P.; Pounds, J.; Adkins, J.; Qian, X.; Wang, R.; Wasinger, V.; Wu, C. Y.; Zhao, X.; Zeng, R.; Archakov, A.; Tsugita, A.; Beer, I.; Pandey, A.; Pisano, M.; Andrews, P.; Tammen, H.; Speicher, D. W.; Hanash, S. M. Overview of the HUPO Plasma Proteome Project: Results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publiclyavailable database. Proteomics 2005, 5 (13), 3226-3245.
6. States, D. J.; Omenn, G. S.; Blackwell, T. W.; Fermin, D.; Eng, J.; Speicher, D. W.; Hanash, S. M. Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study. Nat. Biotechnol. 2006, 24 (3), 333-338.
7. Tuck, M. K.; Chan, D. W.; Chia, D.; Godwin, A. K.; Grizzle, W. E.; Krueger, K. E.; Rom, W.; Sanda, M.; Sorbara, L.; Stass, S.; Wang, W.; Brenner, D. E. Standard Operating Procedures for Serum and Plasma Collection: Early Detection Research Network Consensus Statement Standard Operating Procedure Integration Working Group. J. Proteome Res. 2008, 8 (1), 113-117.
8. Teahan, O.; Gamble, S.; Holmes, E.; Waxman, J.; Nicholson, J. K.; Bevan, C.; Keun, H. C. Impact of Analytical Bias in Metabonomic Studies of Human Blood Serum and Plasma. Anal. Chem. 2006, 78 (13), 4307-4318.
9. Misek, D. E.; Kuick, R.; Wang, H.; Galchev, V.; Deng, B.; Zhao, R.; Tra, J.; Pisano, M. R.; Amunugama, R.; Allen, D.; Walker, A. K.; Strahler, J. R.; Andrews, P.; Omenn, G. S.; Hanash, S. M. A wide range of protein isoforms in serum and plasma uncovered by a quantitative intact protein analysis system. Proteomics 2005, 5 (13), 3343-3352.
10. Lum, G.; Gambino, S. A comparison of serum versus heparinized plasma for routine clinical tests. Am. J. Clin. Pathol. 1974, 61, 108-113.
11. George, J. N.; Thoi, L. L.; McManus, L. M.; Reimann, T. A. Isolation of human platelet membrane microparticles from plasma and serum. Blood 1982, 60 (4), 834-840.
12. Laboratory Methods Committee of the Lipid Research Clinics Program of the National Heart, Lunch, and Blood Institute. Cholesterol and triglyceride concentrations in serum/plasma pairs. Clin. Chem. 1977, 60-63.
13. Folsom, A.; Kuba, K.; Luepker, R.; Jacobs, D.; Frantz, I. Lipid Concentrations in Serum and EDTA-Treated Plasma from Fasting and Nonfasting Normal Persons, with Particular Regard to High-Density Lipoprotein Cholesterol. Clin. Chem. 1983, 29 (3), 505-508.
14. Spence, G.; Graham, A.; Mulholland, K.; McAllister, I.; Sloan, J.; Armstrong, M.; Campbell, F.; McGuigan, J. Vascular endothelial growth factor levels in serum and plasma following esophageal cancer resection-relationship to platelet count. Int. J. Biol. Markers 2002, 17 (2), 119-24.
15. Yang, Z.; Hancock, W. S.; Chew, T. R.; Bonilla, L. A study of glycoproteins in human serum and plasma reference standards (HUPO) using multilectin affinity chromatography coupled with RPLC-MS/MS. Proteomics 2005, 5 (13), 3353-3366.
16. Herrick, S.; Blanc-Brude, O.; Gray, A.; Laurent, G. Fibrinogen. Int. J. Biochem. Cell Biol. 1999, 31 (7), 741-746.
17. Henschen, A.; McDonagh, J., Fibrinogen, fibrin and factor XIII. In Blood Coagulation; Zwaal, R. F. A., Hemker, H. C., Eds. Elsevier: Amsterdam, 1986; pp 171-241.
18. Bones, J.; Mittermayr, S.;O'Donoghue, N.; Guttman, A.; Rudd, P. M. Ultra performance liquid chromatographic profiling of serum Nglycans for fast and efficient identification of cancer associated alterations in glycosylation. Anal. Chem. 2010, 82 (24), 10208-15.
19. Coss, K. P.; Byrne, J. C.; Coman, D. J.; Adamczyk, B.; Abrahams, J. L.; Saldova, R.; Brown, A. Y.; Walsh, O.; Hendroff, U.; Carolan, C.; Rudd, P. M.; Treacy, E. P. IgG N-glycans as potential biomarkers for determining galactose tolerance in classical galactosaemia. Mol. Genet. Metab. 2012, 105 (2), 212-220.
20. Saldova, R.; Royle, L.; Radcliffe, C. M.; Abd Hamid, U. M.; Evans, R.; Arnold, J. N.; Banks, R. E.; Hutson, R.; Harvey, D. J.; Antrobus, R.; Petrescu, S. M.; Dwek, R. A.; Rudd, P. M. Ovarian Cancer is Associated with Changes in Glycosylation in Both Acute-Phase Proteins and IgG. Glycobiology 2007, 17 (12), 1344-1356.
21. Adamczyk, B.; Tharmalingam, T.; Rudd, P. M. Glycans as cancer biomarkers. Biochim. Biophys. Acta, Gen. Subj. 2012, 1820 (9), 1347-53.
22. Olajos, M.; Hajos, P.; Bonn, G. K.; Guttman, A. Sample Preparation for the Analysis of Complex Carbohydrates by Multicapillary Gel Electrophoresis with Light-Emitting Diode Induced Fluorescence Detection. Anal. Chem. 2008, 80 (11), 4241-4246.
23. Harvey, D. J.; Merry, A. H.; Royle, L.; P. Campbell, M.; Dwek, R. A.; Rudd, P. M. Proposal for a standard system for drawing structural diagrams of N-and O-linked carbohydrates and related compounds. Proteomics 2009, 9 (15), 3796-3801.
24. Royle, L.; Campbell, M. P.; Radcliffe, C. M.; White, D. M.; Harvey, D. J.; Abrahams, J. L.; Kim, Y.-G.; Henry, G. W.; Shadick, N. A.; Weinblatt, M. E.; Lee, D. M.; Rudd, P. M.; Dwek, R. A. HPLC-basedanalysis of serum N-glycans on a 96-well plate platform with dedicated database software. Anal. Biochem. 2008, 376 (1), 1-12.
25. Royle, L.; Radcliffe, C. M.; Dwek, R. A.; Rudd, P. M., Detailed Structural Anlysis of N-glycans Released From Glycoproteins in SDSPAGE Gel Bands Using HPLC Combined With Exoglycosidase Array Digestions. In Methods in Molecular Biology; Brockhausen, I., Ed.; Humana Press Inc.: Totowa, NJ, 2006; Vol. 347, Glycobiology Protocols, pp 125-143.
26. Campbell, M. P.; Royle, L.; Radcliffe, C. M.; Dwek, R. A.; Rudd, P. M. GlycoBase and autoGU: tools for HPLC-based glycan analysis. Bioinformatics 2008, 24 (9), 1214-1216.
27. Hilliard, M.; Struwe, W.; Carta, G.; O'Rourke, J.; McLoughlin, N.; Rudd, P. M.; Qing, Y., A Systematic Approach to Glycan Analysis Using HILIC-UPLC and an Online Database of Standardized Values. Application Note, 2012, http://goo.gl/yKJjt.
28. Knezevic, A.; Polasek, O.; Gornik, O.; Rudan, I.; Campbell, H.; Hayward, C.; Wright, A.; Kolcic, I.; O'Donoghue, N.; Bones, J.; Rudd, P. M.; Lauc, G. Variability, Heritability and Environmental Determinants of Human Plasma N-Glycome. J. Proteome Res. 2008, 8 (2), 694-701.
29. Dube, D. H.; Bertozzi, C. R. Glycans in cancer and inflammation [mdash] potential for therapeutics and diagnostics. Nat. Rev. Drug Discovery 2005, 4 (6), 477-488.
30. An, H. J.; Kronewitter, S. R.; de Leoz, M. L. A.; Lebrilla, C. B. Glycomics and disease markers. Curr. Opin. Chem. Biol. 2009, 13 (5-6), 601-607.
31. Miyoshi, E.; Nakano, M. Fucosylated haptoglobin is a novel marker for pancreatic cancer: Detailed analyses of oligosaccharide structures. Proteomics 2008, 8 (16), 3257-3262.
32. Sato, Y.; Takahashi, M.; Shibukawa, Y.; Jain, S. K.; Hamaoka, R.; Miyagawa, J.-i.; Yaginuma, Y.; Honke, K.; Ishikawa, M.; Taniguchi, N. Overexpression of N-Acetylglucosaminyltransferase III Enhances the Epidermal Growth Factor-induced Phosphorylation of ERK in HeLaS3 Cells by Up-regulation of the Internalization Rate of the Receptors. J. Biol. Chem. 2001, 276 (15), 11956-11962.
33. Matsumoto, K.; Yokote, H.; Arao, T.; Maegawa, M.; Tanaka, K.; Fujita, Y.; Shimizu, C.; Hanafusa, T.; Fujiwara, Y.; Nishio, K. N-Glycan fucosylation of epidermal growth factor receptor modulates receptor activity and sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor. Cancer Sci. 2008, 99 (8), 1611-1617.
34. Sarrats, A.; Saldova, R.; Comet, J.; O'Donoghue, N.; de Llorens, R.; Rudd, P. M.; Peracaula, R. Glycan characterization of PSA 2-DE subforms from serum and seminal plasma. OMICS 2010, 14 (4), 465-474.
35. Scherer, H. U.; van der Woude, D.; Ioan-Facsinay, A.; el Bannoudi, H.; Trouw, L. A.; Wang, J.; Ha?upl, T.; Burmester, G.-R.; Deelder, A. M.; Huizinga, T. W. J.; Wuhrer, M.; Toes, R. E. M. Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid. Arthritis & Rheumatism 2010, 62 (6), 1620-1629.
36. Stanta, J. L.; Saldova, R.; Struwe, W. B.; Byrne, J. C.; Leweke, F. M.; Rothermund, M.; Rahmoune, H.; Levin, Y.; Guest, P. C.; Bahn, S.; Rudd, P. M. Identification of N-Glycosylation Changes in the CSF and Serum in Patients with Schizophrenia. J. Proteome Res. 2010, 9 (9), 4476-4489.
37. Guillard, M.; Morava, E.; van Delft, F. L.; Hague, R.; Korner, C.; Adamowicz, M.; Wevers, R. A.; Lefeber, D. J. Plasma N-Glycan Profiling by Mass Spectrometry for Congenital Disorders of Glycosylation Type II. Clin. Chem. 2011, 57 (4), 593-602.
38. Frisch, E.; Kaup, M.; Egerer, K.; Weimann, A.; Tauber, R.; Berger, M.; Blanchard, V. Profiling of Endo H-released serum N-glycans using CE-LIF and MALDI-TOF-MS-Application to rheumatoid arthritis. Electrophoresis 2011, 32 (24), 3510-3515.
39. Henschen-Edman, A. H. Fibrinogen Non-Inherited Heterogeneity and Its Relationship to Function in Health and Disease. Ann. N.Y. Acad. Sci. 2006, 936 (1), 580-593.
40. Henschen-Edman, A. H.; Cao, V.; Galanakis, D. Screening of adult and fetal human fibrinogen with matrix-assisted laser-desorption ionization time-of-flight (MALDI-TOF) mass spectrometry. Blood Coagulation Fibrinolysis 1998, 9 (7), 698.
41. Topfer-Petersen, E.; Lottspeich, F.; Henschen, A. Carbohydrate linkage site in the beta-chain of human fibrin. Hoppe-Seyler's Z. Physiol. Chem. 1976, 357, 1509-1513.
42. Knez?evic?, A.; Gornik, O.; Polas?ek, O.; Puc?ic?, M.; Redz?ic?, I.; Novokmet, M.; Rudd, P. M.; Wright, A. F.; Campbell, H.; Rudan, I.; Lauc, G. Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-glycans. Glycobiology 2010, 20 (8), 959-969.